Molecular Partners Ag (MOLN) Prepaid Assets (2020 - 2026)
Molecular Partners Ag (MOLN) posted quarterly Prepaid Assets of $2358.6 for Q1 2026, up 2.49% year-on-year from $2301.2 in Q1 2025, and down 5.03% on a QoQ basis from $2483.6 in Q4 2025.
Molecular Partners Ag (MOLN) Prepaid Assets (2020 - 2026) Analysis & Trends
Molecular Partners Ag (MOLN) has reported Prepaid Assets for 7 consecutive years, with $2358.6 the latest figure, recorded in Q1 2026.
- Quarterly Prepaid Assets rose 2.49% year-over-year to $2358.6 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2358.6 (up 2.49% YoY) and the FY2025 annual result came in at $2483.6, down 99.91% from the prior year.
- Prepaid Assets eased to $2358.6 in Q1 2026 per MOLN's latest filing, from $2483.6 in the prior quarter.
- Over the last five years, Prepaid Assets for MOLN reached as high as $4.8 million in Q4 2022 and fell as low as $2301.2 in Q1 2025.
- A 5-year average of $1.4 million and a median of $3988.6 in 2023 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets grew 15.9% — and 2025, when it sank 99.91%.
- Year by year, Prepaid Assets stood at $4.8 million in 2022, then retreated by 14.4% to $4.1 million in 2023, then declined by 29.31% to $2.9 million in 2024, then plunged by 99.91% to $2483.6 in 2025, then declined by 5.03% to $2358.6 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $2358.6, $2483.6, and $2919.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Molecular Partners Ag | 147.97 Mn | 147.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,358.63 |
| Dec 31, 2025 | 2,483.57 |
| Sep 30, 2025 | 2,919.01 |
| Jun 30, 2025 | 2,989.53 |
| Mar 31, 2025 | 2,301.25 |
| Dec 31, 2024 | 2.88 Mn |
| Sep 30, 2024 | 2,995.17 |
| Jun 30, 2024 | 3.44 Mn |
| Mar 31, 2024 | 3,292.69 |
| Dec 31, 2023 | 4.08 Mn |
| Sep 30, 2023 | 3,988.57 |
| Jun 30, 2023 | 4.62 Mn |
| Mar 31, 2023 | 3,635.95 |
| Dec 31, 2022 | 4.76 Mn |
| Sep 30, 2022 | 4,995.04 |
| Jun 30, 2022 | 3.99 Mn |
| Mar 31, 2022 | 4,207.79 |
| Dec 31, 2021 | 6.21 Mn |
| Sep 30, 2021 | 8,512.63 |
| Dec 31, 2020 | 1,387.12 |